Schrödinger

formerly SchrodingerIPO

Physics-based Software Platform for Molecular Discovery & Design

Schrödinger is an artificial intelligence company in New York, United States, founded in 1990. It has raised $205.0M across 4 rounds, most recently a $10.0M Grant in July 2024.

Headquarters
New York, New York
Employees
501–1000
Founded
1990
Business Model
B2B
Total Funding
$205.0M
Last Round
$10.0M GrantJul 2024
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 9 investors for this company. to use credits for reveals, or explore the API.

About

Schrödinger's computational platform, powered by physics and machine learning, is transforming drug discovery and materials design. With ~900 employees across 12+ offices globally, the company serves biopharmaceutical and industrial customers, academic institutions, and government labs with tools including Maestro, FEP+, and PyMOL for molecular modeling and in silico prediction.

Funding & Exit History

Data from Indexed.vcUpdated
GrantJul 2024
$10.0M

4 more events

  • IPO2020
  • Series E20198 investors
  • Series E20194 investors

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Other ×3
  • Backend ×2
  • DevOps ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech
Private EquityTotal funding$2.3BFeb 2020
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Schrödinger on Indexed.vc
<a href="https://indexed.vc/companies/schrodinger"><img src="https://indexed.vc/api/badge/company/schrodinger" alt="Schrödinger on Indexed.vc" width="260" height="76" /></a>